A new delivery system for the CentraSight treatment program, which includes a telescope implant for treatment of age-related macular degeneration, has received CE mark, according to a press release from VisionCare.
The Tsert-Si includes a preloaded telescopic implant with foldable haptics that can be delivered through a 6.5-mm incision in patients with end-stage age-related macular degeneration.
In the United States, the CentraSight treatment program is indicated for patients with end-stage AMD “who meet specific eye health and vision requirements, and for whom common treatments such as
Uncategorized